Company History

  • January 2011

    China Biologic purchased the remaining 10% equity in Guiyang Dalin Biologic Technologies Co., Ltd.
  • December 2010

    Shandong Taibang’s newly built plasma collection station in Yishui county obtained plasma collection license from the Shandong Provincial Health Department and commenced commercial plasma collection.
  • December 2010

    KPMG was appointed by the Board of Directors as the auditor to further enhance the quality of the company’s financial reporting practices.
  • April 2010

    Shandong Taibang was designated as a “National Center of Excellence for New Drug and Technology Development” by the Department of Science and Technology of Shandong province, making it eligible to implement and advance major drug development strategies proposed by China's Ministry of Science and Technology.
FirstPage | PreviousPage | NextPage | LastPage CurrentPageIndex:9 [4] [5] [6] [7] [8] [9] [10] [11] [12] 
© 2018 China Biologic Products Holdings, Inc. All Rights Reserved.